ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

In Brief: Owens Gives Up Hopkins Hospital Presidency, Resume Full Time Role As Center Director

July 15, 1988

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994